Cargando…
The lysosome as a novel therapeutic target of EGFR-mediated tumor inflammation
EGFR-mediated tumors have been targeted to overcome several different malignant cancers. EGFR overexpression and mutations are directly related to the malignancy, which makes the therapy more complicated. One reason for the malignancy is the induction of AP1 followed by inflammation via IL-6 secreti...
Autores principales: | Sung, Woo Jung, Kim, Dohyang, Zhu, Anlin, Cho, Namki, Yoo, Hee Min, Noh, Ji Heon, Kim, Kyoung Mi, Lee, Hyun-Su, Hong, Jaewoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691834/ https://www.ncbi.nlm.nih.gov/pubmed/36438839 http://dx.doi.org/10.3389/fphar.2022.1050758 |
Ejemplares similares
-
High-Grade Endometrial Stromal Sarcoma: Molecular Alterations and Potential Immunotherapeutic Strategies
por: Kim, Youngah, et al.
Publicado: (2022) -
EGFR is a potential dual molecular target for cancer and Alzheimer’s disease
por: Choi, Hee-Jeong, et al.
Publicado: (2023) -
Lysosome-Targeted Biosensor for the Super-Resolution Imaging of Lysosome–Mitochondrion Interaction
por: Wang, Han, et al.
Publicado: (2022) -
Targeting lncRNAs of colorectal cancers with natural products
por: Sung, Woo Jung, et al.
Publicado: (2023) -
Inhibition of Nitric Oxide Production in BV2 Microglial Cells by Triterpenes from Tetrapanax papyriferus
por: Cho, Namki, et al.
Publicado: (2016)